Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib

Creative Commons License

Kus T., Aktas G., Sevinc A., KALENDER M. E., YILMAZ M., KUL S., ...Daha Fazla

ONCOTARGETS AND THERAPY, cilt.8, ss.3749-3756, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8
  • Basım Tarihi: 2015
  • Doi Numarası: 10.2147/ott.s94945
  • Dergi Adı: ONCOTARGETS AND THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3749-3756
  • Anahtar Kelimeler: lung adenocarcinoma, erlotinib, F-18-fluorodeoxyglucose positron emission tomography/computed tomography, maximum standardized uptake value, treatment response, prognosis, PLATINUM-BASED CHEMOTHERAPY, OPEN-LABEL, PHASE-III, 2ND-LINE TREATMENT, SMOKING HISTORY, SUPPORTIVE CARE, EGFR MUTATIONS, CANCER, GEFITINIB, MULTICENTER
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: To investigate whether the initial maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) has a prognostic significance in metastatic lung adenocarcinoma.